SAP SE (0A2W)
London Stock Exchange · UK · prices in USD · close of 30 Oct 2026
Key indicators
| Last close | USD 238.34 |
|---|---|
| 52-week range | 172.23 – 283.25 |
| Return, 1 month / 3 months | +38.4% / +38.4% |
| Return, 1 year / 3 years | −14.4% / +85.3% |
| Trend | Uptrend |
| RSI (14) | 94 |
| Volatility (1 year) | 49.2% |
| Worst drawdown (1 year) | -39.2% |
| Average daily value traded | 0.00M USD |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SAP SE is a German software company based in Walldorf that supplies business application software to organisations of many sizes. Its main offerings include enterprise resource planning systems, which help companies manage finance, procurement, manufacturing, supply chains and human resources in one place. SAP also provides cloud-based services, data and analytics tools, and industry-specific applications. Its customers span manufacturers, retailers, service providers and public sector bodies around the world.
SAP SE trades under the code 0A2W on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SAP SE (0A2W) trades on the London Stock Exchange in UK. It last closed at USD 238.34 on 30 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 2,491 of 3,790 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.4% and over the last three months it rose 38.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 25.7% | ||
| From 52-week high | -15.9% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 38.4% | ||
| 6-month return | 40.8% | ||
| 12-month return, skipping the last month | -38.1% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.2% | ||
| Liquidity | 3 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M USD | ||
| Zero-volume days | 95.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +38.4% |
|---|---|
| 1 month | +38.4% |
| 3 months | +38.4% |
| 6 months | +40.8% |
| 1 year | −14.4% |
| 3 years | +85.3% |
| 5 years | +75.0% |
Signals
| 50-day / 200-day average | 176.14 / 189.59 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2026 | EUR 2.9291 |
| 13 May 2025 | EUR 2.6298 |
| 16 May 2024 | EUR 2.3913 |
| 12 May 2023 | EUR 2.2330 |
| 19 May 2022 | EUR 2.0762 |
| 13 May 2021 | EUR 2.2599 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.